WebApr 11, 2024 · Company also presenting at upcoming investor conferences. WATERTOWN, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), … WebMar 17, 2024 · About Kymera Therapeutics, Inc. 200 ARSENAL YARDS BOULEVARD SUITE 230, WATERTOWN, Massachusetts, 2472, United States +1 857 285-5300 …

Kymera Therapeutics (KYMR) Price To Cash Flow - Zacks.com

WebApr 13, 2024 · Mentioned in this article. Kymera Therapeutics Inc ( KYMR) is near the top in its industry group according to InvestorsObserver. KYMR gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Kymera Therapeutics Inc gets a 75 rank in the Biotechnology industry. Biotechnology is number 30 out of 148 industries. WebStock analysis for Kymera Therapeutics Inc (KYMR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. hyperthyreose radiojodtherapie

Kymera Therapeutics, Inc. (KYMR) - Yahoo Finance

WebKymera Therapeutics stock price target cut to $50 from $67 at B. Riley May. 4, 2024 at 8:06 a.m. ET by Tomi Kilgore Kymera Therapeutics started at neutral with $44 stock price … WebKymera Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. KYMR updated stock price target summary. WebApr 14, 2024 · Kymera Therapeutics Inc (KYMR) stock is trading at $32.70 as of 2:02 PM on Friday, Apr 14, a drop of -$0.69, or -2.07% from the previous closing price of $33.39. The stock has traded between $32.27 and $33.78 so far today. Volume today is less active than usual. So far 105,206 shares have traded compared to average volume of 435,652 shares. hyperthyreose osteoporose